Origin of childhood cancer malignant rhabdoid tumour discovered
Automated next generation sequencing platform can accurately screen thousands for COVID-19
3 March 2021Single vaccine dose may offer protection to those who have had COVID-19
3 March 2021Origin of childhood cancer malignant rhabdoid tumour discovered
The first proof of the origin of malignant rhabdoid tumor (MRT), a rare childhood cancer, has been discovered by researchers at the Wellcome Sanger Institute, the Princess Máxima Center for Pediatric Oncology in the Netherlands, and their collaborators.
